Investor Relations
Company Overview
HistoRx is developing novel diagnostic solutions to enable new approaches to individualized patient care. The company accomplishes this through analysis of protein biomarkers in tissue using its proprietary AQUA® technology. These reproducible and quantifiable tissue-based immunoassays correlate protein expression with disease outcome.
Core Technology
AQUA technology is an automated image-analysis platform that brings objective results to protein measurement in tissue. Its quantitative, localized and reproducible analyses provide new insights into cancer treatment. HistoRx is applying these tissue-based immunoassays to both drug discovery & development and to clinical diagnostics that drive treatment decisions.
Current investors include:
- Brook Venture
- Common's Capital
- Maven Biocapital
- Navigator Technology Ventures (Draper Laboratories)
- Private Investors
- Roche Ventures
If you are interested in investing in HistoRx, please contact Rana Gupta.
Phone: 203-498-7500
Email- investor@historx.com